BGI Genomics Co (SZSE:300676) 3-Year EBITDA Growth Rate : -39.60% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is BGI Genomics Co 3-Year EBITDA Growth Rate?

BGI Genomics Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.08.

During the past 12 months, BGI Genomics Co's average EBITDA Per Share Growth Rate was -77.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -39.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 7.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 10.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of BGI Genomics Co was 64.10% per year. The lowest was -39.60% per year. And the median was 9.80% per year.

Competitive Comparison of BGI Genomics Co's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, BGI Genomics Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BGI Genomics Co's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BGI Genomics Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where BGI Genomics Co's 3-Year EBITDA Growth Rate falls into.

BGI Genomics Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

BGI Genomics Co (SZSE:300676) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

BGI Genomics Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of BGI Genomics Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

BGI Genomics Co (SZSE:300676) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BGI Genomics Co Ltd (SZSE:300676) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

21 Hongan Third Street, Dong, Huada Complex Park, Yantian District, Shenzhen, CHN, 518083

Website

http://www.bgi.com

BGI Genomics Co Ltd is a China-based company principally engaged in the provision of genomic class diagnosis and research services through the application of biotechnology. It offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company mainly provides services for domestic and overseas academic institutions hospitals, medical institutions and others.

BGI Genomics Co (SZSE:300676) Headlines

No Headlines